Sheldon Sloan
Chief Medical OfficerDr. Sheldon Sloan, M.D., M.B.E., M. Bioethics, is Chief Medical Officer of Spyre Therapeutics, Inc. from October 2024. Dr. Sloan was Chief Medical Officer at ABIVAX Société Anonyme since March 2023 until July 2024. He has experience in academia and the biopharmaceutical industry, with an extensive track record in the field of gastroenterology and IBD. Prior to joining Abivax, Dr. Sloan worked for Arena Pharmaceuticals and after its acquisition, for Pfizer. He was Program Lead for Etrasimod UC, responsible for cross-functional leadership, planning and management, operational business process planning and execution management of the Ulcerative Colitis program, including its global submission and launch. Before joining Arena Pharmaceuticals, Dr. Sloan held different leadership positions at J&J in Medical Affairs, R&D and Science Policy. In his last position at J&J, he was Global Medical Affairs Leader for IBD, leading the global launch strategy and execution for Crohn’s Disease and Ulcerative Colitis for Stelara. Dr. Sloan also has a strong track record in bioethics and has been involved on different levels in questions addressing bioethics issues including animal care and use and human subjects research. Dr. Sloan serves on the Columbia University Masters of Bioethics Advisory Board, the Drexel University Dornsife School of Public Health Dean's Impact and Advancement and Learning Council. He holds an M.D. from Rush Medical College, Chicago, USA and a Master of Bioethics from the University of Pennsylvania, USA. He has authored a large number of scientific publications and abstracts and contributed to various books in the gastroenterology and immunology fields.
Positions
- Company NameSpyre Therapeutics, Inc.Stock CodeSYREPositionChief Medical OfficerColleagues
- CTCameron TurtleCEO & Director
- JWJeffrey W. AlbersIndependent Chairman of the Board
- SLScott L. BurrowsChief Financial Officer
- HAHeidy Abreu King-JonesChief Legal Officer & Corporate Secretary
- JGJanet Gunzner-TosteSenior Vice President of Operations
- LDLaurie D. StelzerIndependent Director
- SMSandra MilliganIndependent Director
- KTKeith T. FlahertyMember of Scientific Advisory Board
